InsidersTradesSigma
Browse the full record of transactions filed by Downs Christopher, Chief Financial Officer. Insider active across 1 companies, notably CNS Pharmaceuticals, Inc.. Aggregated, 5 filings have been logged. Total volume traded: €17k. The latest transaction was disclosed on 11 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
5 of 5 declarations
Christopher Downs is the Chief Financial Officer of CNS Pharmaceuticals, Inc. He is responsible for the financial management of the company, overseeing financial operations and strategic planning. Christopher plays a key role in optimizing financial performance and achieving CNS Pharmaceuticals' growth objectives.